I received a very disturbing notice from Cancer Care about their ability to provide financial support for men with cancer, including men with prostate cancer. As of August 6, 2012 they will not be able to accept applications or provide assistance to men with cancer unless they meet the following criteria: 1- Men diagnosed with [...]
At a recent meeting that I attended it was reported by a nurse that one of her patients with advanced prostate cancer with only a PSA recurrence and lymph node involvement on a scan was rejected by their insurance company for reimbursement for Provenge. The insurance company indicated that to pay for the treatment they [...]
Cancer Care has announced two changes in their financial assistance program procedures. These changes take effect immediately: 1- Applications for assistance will not be accepted unless the applicant has spoken to a Cancer Care representative in advance of filling out the application. To apply contact a Cancer Care oncology social worker via their toll-free Hopeline, [...]
Yesterday May 16, 2012, the House Appropriations Committee released their draft committee report to accompany the FY13 Defense Appropriations Act. This draft included the CDMRP requested budget for 2013. The good news is that the ask includes $80 million dollars for the Prostate Cancer Research Program. Although this is the same amount prostate cancer received [...]
Historically, I have been critical of the FDA, especially around the delay of the approval of Provenge. Now, it is time to take a look at the FDA and what I believe the future will be for this agency. I do first need to make it clear that I do believe that the FDA plays [...]